Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Abolaji Atomode
Observed names:
A Atomode,
A. Atomode,
Atomode, Abolaji
Observed institution:
Liverpool University Hospitals NHS Foundation Trust
ORCID:
0000-0002-6154-2466
Observed ORCID:
0000-0002-6154-2466
OpenAlex ID:
A5079497164
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
324
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
129
Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study
2022
·
Douglas L Fink
, Douglas L Fink
, et al.
·
The Lancet Infectious Diseases
·
98
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
O Abani
, A Abbas
, et al.
·
The Lancet Diabetes & Endocrinology
·
41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
Saul N Faust
, Richard Haynes
, et al.
·
The Lancet Child & Adolescent Health
·
39
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
·
12
PDF
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
RECOVERY Collaborative Group
, Peter Sandercock
, et al.
·
Nature Communications
·
11
PDF
Exploring the views of infection consultants in England on a novel delinked funding model for antimicrobials: the SMASH study
2023
·
Ioannis Baltas
, Mark Gilchrist
, et al.
·
JAC-Antimicrobial Resistance
·
7
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O. Abani
, A. Abbas
, et al.
·
EClinicalMedicine
·
5
Incidence, risk factors and management of paradoxical reaction in central nervous system tuberculosis in the United Kingdom
2026
·
Emma C. Carter
, Cristina Fernandez
, et al.
·
Journal of Infection
PDF
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
PDF
25 Exploring the views of infectious diseases and microbiology consultants in England on a novel delinked funding model for antimicrobials: The SMASH study
2023
·
Ioannis Baltas
, Mark Gilchrist
, et al.
·
Clinical Infection in Practice
Tick-borne Encephalitis in a 29-Year-Old Returning Traveller
2021
·
Abolaji Atomode
, Hassan Haruna
, et al.
·
American journal of infectious diseases and microbiology
Spontaneous Pan-Vertebral Epidural Abscesses Caused by Streptococcus Intermedius in an Immunocompetent Patient
2020
·
Odega Emmanuel
, Abolaji Atomode
, et al.
·
American journal of infectious diseases and microbiology
Show more works
View as search
Works count:
17
Citation count:
666
H-index:
7
I10-index:
7
Year
Topic
Type